Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Clin Gerontol. 2018 Jun 25;43(3):266–280. doi: 10.1080/07317115.2018.1485812

Table 8.

Results of chi-square test and descriptive statistics for cognitive status by FDA by SFE.

Cognitive Status FDA No SFE SFE
WNL1 No Concerns 135 (86%) 22 (14%)
Some/Major Concerns 3 (60%) 2 (40%)
Total 138 24
PCD2 No Concerns 23 (85.2%) 4 (14.8%)
Some/Major Concerns 3 (27.3%) 8 (72.7%)
Total 26 12

Note: FDA = Financial Decisional Abilities; SFE = Suspected financial exploitation; WNL = Within normal limits; PCD =Possible cognitive decline. Numbers in parentheses indicate row percentages within cognitive status group.

1

X2 = 2.59, df = 1, p = .107.

2

X2 = 12.132, df = 1, p < .001.